Screening for breast cancer with MRI

被引:25
作者
Morris, EA [1 ]
机构
[1] Cornell Univ, Dept Radiol, Mem Sloan Kettering Canc Ctr, Weill Med Coll, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0887-2171(03)90025-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Breast MRI has emerged as an extremely powerful tool in breast imaging. The use of breast MRI for cancer detection has the potential to change our current algorithms in the detection of breast cancer. By being able to detect cancer that is occult on conventional imaging, such as mammography and sonography, MRI can detect early breast cancer that was previously unseen by conventional imaging. This article reviews the experience of screening breast MRI in the high-risk population. It also reviews the limitations associated with its use. Before breast MRI can be used in the clinical setting, an ability to localize or biopsy MRI detected lesions that are occult on mammography and ultrasound is needed and must be available for these patients. Although the robustness of this technique has generated considerable enthusiasm, our perspective should be tempered by the fact that many questions remain unanswered regarding the use of breast MRI for screening in the nonhigh risk population as well as integration of breast MRI into clinical practice. Copyright 2003, Elsevier Science (USA). All rights reserved.
引用
收藏
页码:45 / 54
页数:10
相关论文
共 50 条
[1]   BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair [J].
Abbott, DW ;
Thompson, ME ;
Robinson-Benion, C ;
Tomlinson, G ;
Jensen, RA ;
Holt, JT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18808-18812
[2]   Breast cancer screening for high-risk women: Too little, too late? [J].
Armstrong, K ;
Weber, BL .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :919-920
[4]   False-negative MR imaging of malignant breast tumors [J].
Boetes, C ;
Strijk, SP ;
Holland, R ;
Barentsz, JO ;
VanderSluis, RF ;
Ruijs, JHJ .
EUROPEAN RADIOLOGY, 1997, 7 (08) :1231-1234
[5]  
Boetes C, 2001, Magn Reson Imaging Clin N Am, V9, P357
[6]   Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk [J].
Brekelmans, CTM ;
Seynaeve, C ;
Bartels, CCM ;
Tilanus-Linthorst, MMA ;
Meijers-Heijboer, EJ ;
Crepin, CMG ;
van Geel, AN ;
Menke, M ;
Verhoog, LC ;
van den Ouweland, A ;
Obdeijn, IM ;
Klijn, JGM .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :924-930
[7]   Incidental findings on sonography of the breast:: Clinical significance and diagnostic workup [J].
Buchberger, W ;
DeKoekkoek-Doll, P ;
Springer, P ;
Obrist, P ;
Dünser, M .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1999, 173 (04) :921-927
[8]   Recommendations for follow-up care of individuals with an inherited predisposition to cancer .2. BRCA1 and BRCA2 [J].
Burke, W ;
Daly, M ;
Garber, J ;
Botkin, J ;
Kahn, MJE ;
Lynch, P ;
McTierman, A ;
Offit, K ;
Perlman, J ;
Petersen, G ;
Thomson, E ;
Varricchio, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (12) :997-1003
[9]   Interactive MR-guided, 14-gauge core-needle biopsy of enhancing lesions in a breast phantom model [J].
Daniel, BL ;
Birdwell, RL ;
Black, JW ;
Ikeda, DM ;
Glover, GH ;
Herfkens, RJ .
ACADEMIC RADIOLOGY, 1997, 4 (07) :508-512
[10]   Mammographic screening of the high-risk woman [J].
Dershaw, DD .
AMERICAN JOURNAL OF SURGERY, 2000, 180 (04) :288-289